Portolés A, Rojo J M, Díaz R
Rev Esp Fisiol. 1984 Sep;40(3):297-309.
Pharmacological changes in a model of passive anaphylaxis by immune complexes in mice have been studied. The results have been evaluated by nomograms to overcome the difficulties observed when using classical criteria as 50% lethal dosis or 50% infective dosis in experimental models which do not allow serial dilutions of the reagents. Mean lethal time, maximal pathogenic capacity and relative survival time can be easily determined, allowing the comparison of the immunopharmacologic protection for each administration schedule. By these criteria, we have observed a different degree of anaphylactic reaction depending on the genetic background of the hosts as well as a protection against anaphylactic shock using the antiserotoninic cyproheptadine and, to a lesser extent, by the platelet antiaggregant ticlopidine.
对小鼠免疫复合物被动过敏反应模型中的药理学变化进行了研究。通过列线图对结果进行了评估,以克服在不允许试剂连续稀释的实验模型中使用经典标准(如50%致死剂量或50%感染剂量)时所观察到的困难。平均致死时间、最大致病能力和相对存活时间可以很容易地确定,从而能够比较每种给药方案的免疫药理学保护作用。根据这些标准,我们观察到,取决于宿主的遗传背景,过敏反应程度不同,并且使用抗血清素的赛庚啶以及在较小程度上使用血小板抗聚集剂噻氯匹定可预防过敏性休克。